Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (231-240 of 621) with videos related to

Pageof 63
Sort By:
Frontiers in Immunology|September 10, 2021
Elevated Fibronectin Levels in Profibrotic CD14<sup>+</sup> Monocytes and CD14<sup>+</sup> Macrophages in Systemic SclerosisMichał Rudnik, Amela Hukara, Ievgeniia Kocherova, et al.
Annals of the Rheumatic Diseases|April 11, 2015
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosisJingang Huang, Christian Beyer, Katrin Palumbo-Zerr, et al.
Rheumatology (Oxford, England)|December 13, 2024
Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseasesAmela Hukara, Gino Andrea Bonazza, Tracy Tabib, et al.
Annals of the Rheumatic Diseases|October 10, 2020
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)Paolo Spagnolo, Oliver Distler, Christopher J Ryerson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Rheumatology (Oxford, England)|August 1, 2025
Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosisGesa M Sauer, Florian Käs, Carmen-Marina Mihai, et al.
Annals of the Rheumatic Diseases|January 24, 2012
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosisGerhard Krönke, Nicole Reich, Carina Scholtysek, et al.
Journal of Cellular and Molecular Medicine|September 9, 2008
Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivoPaulius Venalis, Britta Maurer, Alfiya Akhmetshina, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1Katrin Palumbo-Zerr, Angelika Horn, Alfiya Distler, et al.
Molecular Medicine (Cambridge, Mass.)|March 13, 2025
Identification of two biological subgroups of complex regional pain syndrome type 1 by transcriptomic profiling of skin and blood in womenMelina Pérez Vertti Valdés, Astrid Jüngel, Pamela Bitterli, et al.
Pageof 63

Showing results (231-240 of 621) with videos related to

Sort By:
Pageof 63
Frontiers in Immunology|September 10, 2021
Elevated Fibronectin Levels in Profibrotic CD14<sup>+</sup> Monocytes and CD14<sup>+</sup> Macrophages in Systemic SclerosisMichał Rudnik, Amela Hukara, Ievgeniia Kocherova, et al.
Annals of the Rheumatic Diseases|April 11, 2015
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosisJingang Huang, Christian Beyer, Katrin Palumbo-Zerr, et al.
Rheumatology (Oxford, England)|December 13, 2024
Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseasesAmela Hukara, Gino Andrea Bonazza, Tracy Tabib, et al.
Annals of the Rheumatic Diseases|October 10, 2020
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)Paolo Spagnolo, Oliver Distler, Christopher J Ryerson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 11, 2019
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic SclerosisVincent Sobanski, Jonathan Giovannelli, Yannick Allanore, et al.
Rheumatology (Oxford, England)|August 1, 2025
Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosisGesa M Sauer, Florian Käs, Carmen-Marina Mihai, et al.
Annals of the Rheumatic Diseases|January 24, 2012
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosisGerhard Krönke, Nicole Reich, Carina Scholtysek, et al.
Journal of Cellular and Molecular Medicine|September 9, 2008
Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivoPaulius Venalis, Britta Maurer, Alfiya Akhmetshina, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1Katrin Palumbo-Zerr, Angelika Horn, Alfiya Distler, et al.
Molecular Medicine (Cambridge, Mass.)|March 13, 2025
Identification of two biological subgroups of complex regional pain syndrome type 1 by transcriptomic profiling of skin and blood in womenMelina Pérez Vertti Valdés, Astrid Jüngel, Pamela Bitterli, et al.
Pageof 63